| Current Price | $0.49 | Mkt Cap | $19.1M |
|---|---|---|---|
| Open | $0.50 | P/E Ratio | -0.40 |
| Prev. Close | $0.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.49 - $0.51 | Volume | 72,576 |
| 52-Wk Range | $0.44 - $2.47 | Avg. Daily Vol. | 129,896 |
The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.
| Current Price | $0.49 | Mkt Cap | $19.1M |
|---|---|---|---|
| Open | $0.50 | P/E Ratio | -0.40 |
| Prev. Close | $0.50 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.49 - $0.51 | Volume | 72,576 |
| 52-Wk Range | $0.44 - $2.47 | Avg. Daily Vol. | 129,896 |
The best Bull and Bear pitches based on recency and number of recommendations.
If phase 3 trial info is released midterm through the study, and it is as positive and consistent as previous results, the stock will jump remarkably, especially after being beaten down so badly since mid 2010. This thing could easily double or… More
It's been two years since I laid out my thesis for the failure of the VALOR trial at http://caps.fool.com/Pitch/SNSS/6511180/its-clear-that-2012-has-minted.aspx , and almost a month since my prediction came true after countless delays and… More
Read the most recent pitches from players about VIRX.
Recs
techvfund
(51.78)
Submitted: 3/2/2016 1:30:53 PM :
Start Price:
$4.38
NASDAQ:VIRX Score:
-219.83
Top fool Momentum21 liked this one today...top fool zzlangerhans has been trading it since 2011 and wrote a good thesis on same last summer. No opinion on the science myself; its an orphan; technically good entry. Speculate.
Recs
OilRulesTheWorld
(< 20)
Submitted: 7/24/2015 12:54:04 PM :
Start Price:
$5.98
NASDAQ:VIRX Score:
-210.51
Should see a Big Dead Count Bounce from this level.
Recs
HealthcareGuy
(84.20)
Submitted: 7/22/2015 12:58:32 PM :
Start Price:
$21.24
NASDAQ:VIRX Score:
-214.62
They will refile- sell that news
Find the members with the highest scoring picks in VIRX.
zzlangerhans (98.81) Score: +366.53
One of the most predictable faceplants in biopharma this year, but I still couldn't manage to make any significant money off it.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| theminc | < 20 | 10/9/2006 |
|
1Y | $180.00 | -99.72% | +260.78% | +360.51 | 1 Comment | |
| Idrinkbeer | 56.81 | 11/6/2006 |
|
1Y | $194.40 | -99.74% | +255.22% | +354.96 | 0 Comment | |
| EPSDrift | 89.39 | 5/29/2012 |
|
3W | $17.70 | -97.18% | +244.24% | +341.42 | 0 Comment | |
| MFBurritoSquat | 69.32 | 8/15/2012 |
|
3M | $19.02 | -97.37% | +225.26% | +322.63 | 0 Comment | |
| stini01 | 22.02 | 5/8/2007 |
|
3W | $156.96 | -99.68% | +222.37% | +322.05 | 0 Comment | |
| MassProduced | 97.45 | 5/14/2007 |
|
NS | $150.12 | -99.67% | +222.23% | +321.89 | 0 Comment | |
| Azurepoet | 95.02 | 5/14/2007 |
|
NS | $147.96 | -99.66% | +221.24% | +320.91 | 0 Comment | |
| ActiveJunkie | 98.65 | 5/16/2007 |
|
NS | $149.40 | -99.67% | +220.04% | +319.70 | 0 Comment | |
| Toosleepy | 98.69 | 5/21/2007 |
|
NS | $159.84 | -99.69% | +217.60% | +317.29 | 0 Comment | |
| SnarkyApple | 50.57 | 9/28/2012 |
|
3M | $34.02 | -98.53% | +218.13% | +316.66 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
